GlassScriptPhysician profile
Cherady J Ketha
NPI 1225234032
$15,237.64
in general payments reported to CMS, 2019-2025
26 companies · $624 in 2025
The $624 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $89.54 · 2021: $12.08 · 2022: $39.59 · 2023: $14K · 2024: $558 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Food and Beverage: $1,187 · Travel and Lodging: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,553.40 |
| Food and Beverage | $1,187.26 |
| Travel and Lodging | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,653.94 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Sumitomo Pharma America, INC. | $222.18 | 2024-2025 | Myfembree |
| Coopersurgical, INC. | $152.48 | 2019-2024 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Abbvie INC. | $148.19 | 2019-2021 | |
| Millicent US INC | $124.80 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Hologic Sales and Service, LLC | $121.60 | 2024-2025 | Myosure Tissue Removal Device, Novasure, Omni Hysteroscope |
| Astellas Pharma US INC | $86.67 | 2024-2025 | Veozah |
| Therapeuticsmd, INC. | $78.04 | 2019-2020 | |
| Allergan, INC. | $76.88 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.06 | 2019-2025 | |
| Organon LLC | $64.07 | 2022-2025 | Jada System, Nexplanon |
| Biogen, INC. | $49.81 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $49.33 | 2025 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $46.46 | 2025 | |
| Shield Therapeutics INC | $45.88 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $43.23 | 2025 | Slynd |
| Amag Pharmaceuticals, INC. | $38.10 | 2019 | |
| Baxter Healthcare | $34.57 | 2024 | Perclot |
| Aspira Women'S Health INC | $25.09 | 2024 | Ova1 |
| Itamar Medical INC | $18.17 | 2025 | Watchpatone |
| Daiichi Sankyo INC. | $17.05 | 2019 | |
| Gynesonics, INC. | $15.94 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Amgen INC. | $15.29 | 2024 | Evenity, Prolia |
| Optumhealth Care Solutions, LLC | $13.78 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Pfizer INC. | $13.76 | 2024 | |
| Minerva Surgical, INC | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cherady Ketha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.